Price $15.85 |
Market Cap
677.5M
|
Sector Health Care |
Div. Growth
-31.00%
|
|
P/E
40.6
|
P/B
3.86
|
P/S
3.23
|
Dividend %
3.10%
|
|
P/CF
409.9
|
P/FCF
148.1
|
Op. Cash Flow
30.1K
|
FCF
0.1
|
|
Op. Margin
13.80%
|
Net Margin
8.40%
|
ROE
10.30%
|
ROI
10.00%
|
|
ROA
7.00%
|
EPS Growth
-41.30%
|
Current Ratio
5.8
|
Debt/Equity
29.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Health Industries Holdin (CHHE) | $0.95 | - | - | 60.3M | Strong Buy |
| Bovie Medical Corporation (BVX) | $5.23 | - | - | 144.7M | Strong Buy |
| Kalvista Pharmaceuticals Inc (KALV) | $8.70 | - | - | 87.7M | Strong Buy |
| Reliv International, Inc (RELV) | $4.82 | - | - | 8.9M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $22.93 | - | 3.50% | 24.52B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
